CannaPharmaRX, Inc.
CPMD
$0.00
$0.00-4.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 352.74% | -78.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 352.74% | -78.89% | |||
| Cost of Revenue | 73.46% | -49.40% | |||
| Gross Profit | -1.10% | 20.68% | |||
| SG&A Expenses | -60.50% | 37.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.89% | -35.18% | |||
| Operating Income | 23.65% | 4.49% | |||
| Income Before Tax | 94.94% | -410.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 94.94% | -410.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 94.94% | -410.87% | |||
| EBIT | 23.65% | 4.49% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 94.74% | -418.18% | |||
| Normalized Basic EPS | 86.21% | -107.14% | |||
| EPS Diluted | 94.74% | -418.18% | |||
| Normalized Diluted EPS | 86.21% | -107.14% | |||
| Average Basic Shares Outstanding | 1.10% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.10% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||